ABT
Abbott Laboratories
Abbott Laboratories 13F Holders
ABT Stock Ownership Activity
- # of activities:
- 4
- AVG reported price*:
- $88.31
- Current price*:
- +21.65%($107.42)
4 value investing gurus have made changes to the Abbott Laboratories (ABT) position according to the gurus' 2020 Q2 SEC quarterly report(s). ABT has been bought (as a new position) by 1, completely sold out by 1 guru(s), the number of ABT shares has been increased by 1, decreased by 1 super investor(s).
Which gurus or hedge funds bought ABT in 2020 Q2?
According to the 2020 Q2 SEC filing(s) Abbott Laboratories (ABT) has been bought by 2 gurus / funds: Polen Capital Management (added shares +12.32%) and Paul Lountzis - Lountzis Asset Management (new buy).
To see more about who is investing in Abbott Laboratories (ABT), please go to the ABT ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.